With the medical community relentlessly focused on getting the world through the coronavirus pandemic, it comes as no surprise that 2020 was a boon for vaccine makers. While the attention these critical businesses received is well-deserved, there’s a small-cap healthcare stock flying under the radar that’s been better at beating the market.
The Joint Chiropractic (NASDAQ: JYNT), a nationwide franchisor of affordable chiropractic clinics, is benefiting from the general public’s heightened interest in pain relief and wellness. The company went from having 12 total locations in 2010 to 560 as of Sept. 30, 2020. It’s accomplishing this by creating an innovative business model that delivers fantastic financial performance.
Even after posting market-beating returns over the past few years, I believe The Joint Chiropractic could still double your money. Here’s why.